Jeff Finer

Company: Septerna

Job title: Chief Executive Officer

Seminars:

Unlocking Difficult-to-Drug GPCRs with GPCR Native Complexes 12:15 pm

Rapid structure determination to fuel structure-based drug design Expanding chemical space with new hit identification technologies Revealing novel molecular insights of GPCR modulationRead more

day: Day One

Panel Discussion: What Does the Next 5 Years of GPCR Drug Discovery & Development Look Like? 9:00 am

Exploring the current lay of the land; which GPCRs show most promise now and where does the future lie? What technologies are the most exciting right now and will propel the field forward? How do we increase the number of antibody therapeutics in the GPCR marketRead more

day: Day One